KP Ventures invests in medical devices, health care services and health care information technology. The investment portfolio has generated eight successful exits.
Medical Devices Health Care Services
AcelRx (Drug delivery)
Accumetrics (Diagnostic assay)
Adiana (Permanent contraception)*
Arbor Surgical (Cardiac implant)
Arcxis (Molecular diagnostics)
Bacchus Vascular (Vascular device)
Calypso (Tumor localization)
CHF Solutions (Fluid removal)
GeneOhm (Molecular diagnostics)*
Glumetrics (Glycemic monitoring)
GMD (Cost effective medical devices)
NeoGuide (Endoscopic device)
Predictive Biosciences (Cancer diagnostics)
Proteogenix (Maternal-fetal diagnostics)
Proteus (Intelligent Medicine)
ValenTx (Obesity management)
Valeritas (Drug delivery)
Vapotherm (Respiratory therapy)
Zonare (Ultrasound equipment)
Avivia (Disease management)
Broadlane (Procurement services)*
Free & Clear (Smoking cessation)
Health Dialog (Disease care)*
HEARx West (Hearing aid centers)
Nursefinders (Nurse staffing)*
ORC (Renal disease care)*
SilverLink (Communication)
 
Information Technology
BDNA (IT asset management)
Concerro (Scheduling & bidding)
Emageon (Image archiving)*
Healthline (Health care search)
Next Web (Broad band wireless)*
Radianse (Asset tracking)
 
* Equity is publicly tradable or has been acquired.